The pathways and molecules involved in both the tumorigenic and anti-tumorigenic effects of Sirt1 include YAP, FOXO, p53, and miRNAs, whereas the JAK2/STAT3 pathway and ferroptosis are involved in the anti-tumorigenic effect of Sirt6 in gastric cancer. This evidence concerns the gene STAT3 and gastric cancer.